Dr. Simon C Abelson , MD
Internal Medicine • Miami, FL
7085 Sw 47th St
Miami, FL 331554652
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Simon Abelson is listed in NPPES under Internal Medicine.
-
NPI assigned on November 14, 2006; this date does not establish years in practice.
-
Published CMS data list 314 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Alprazolam — 32 prescription fills, including refills.
- Atorvastatin Calcium — 28 prescription fills, including refills.
- Rosuvastatin Calcium — 27 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 17 records in the table · Guide: How to read Medicare Part D prescriber data
-
Fewer Part D prescriptions than 65% of clinicians listed under Internal Medicine in Miami, FL (2024, 449 clinicians with data). Median for this group: 1,329. Middle half: 148 to 5,867.
Fewer Part D prescriptions than 65% of clinicians listed under Internal Medicine in Florida (2024, 6,545 clinicians with data). Median for this group: 1,318. Middle half: 158 to 5,882.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 1,017 in 2020 to 314 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
7085 Sw 47th St
Miami, FL 331554652
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Internal Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
740 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$10,936 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Industry payments (Open Payments)
Fewer than 11 payment records totaling $750.00 in 2024
Drug and medical device companies must report certain payments to doctors and some other clinicians to CMS, such as meals, travel, speaking fees or research funding.
It shows reported financial ties between this clinician and companies. You can ask your clinician about them.
These records are submitted by drug and medical device companies, and a reported payment does not necessarily mean the financial relationship is improper.
General: payments not tied to research, such as meals, travel, consulting or speaking fees.
A reported payment does not necessarily mean the financial relationship is improper. Research payments can go to a hospital or university for a study the clinician leads, not to the clinician personally. Clinicians can dispute records with the company that reported them.
Source: CMS Open Payments, program year 2024.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Abelson has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Abelson as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Miami and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Fewer Part D prescriptions than 65% of clinicians listed under Internal Medicine in Miami, FL (2024, 449 clinicians with data). Median for this group: 1,329. Middle half: 148 to 5,867.
Fewer Part D prescriptions than 65% of clinicians listed under Internal Medicine in Florida (2024, 6,545 clinicians with data). Median for this group: 1,318. Middle half: 158 to 5,882.
Part D drug cost
A lower Part D drug cost than 70% of clinicians listed under Internal Medicine in Miami, FL (2024, 449 clinicians with data). Median for this group: $82,482. Middle half: $7,967 to $424,773.
A lower Part D drug cost than 70% of clinicians listed under Internal Medicine in Florida (2024, 6,545 clinicians with data). Median for this group: $86,865. Middle half: $8,159 to $434,445.
763 active clinicians are listed under Internal Medicine with a practice address in Miami, FL (10,165 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Miami
18.3% of these 763 clinicians have the CMS telehealth indicator.
61.1% of these 763 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 69% from 1,017 in 2020 to 314 in 2024.
- 2020: 1,017
- 2021: 850
- 2022: 597
- 2023: 324
- 2024: 314
-
30-day fills
30-day fills decreased 69% from 2,393 in 2020 to 740 in 2024.
- 2020: 2,393
- 2021: 1,958
- 2022: 1,367
- 2023: 778
- 2024: 740
-
Part D drug cost
Part D drug cost decreased 32% from $15,999 in 2020 to $10,936 in 2024.
- 2020: $15,999
- 2021: $32,753
- 2022: $10,314
- 2023: $2,826
- 2024: $10,936
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 93% from $10,280.53 in 2020 to $750.00 in 2024.
- 2020: $10,280.53
- 2021: $14,329.52
- 2022: $5,876.41
- 2023: $6,527.94
- 2024: $750.00
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2024), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2024 (payments made January 1 – December 31, 2024): fewer than 11 records totaling $750.00.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
MAYZENT | General | $750.00 |
Source: CMS Open Payments, program year 2024, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Alprazolam | Alprazolam | 32 | 1,160 | $169.59 | — |
| Atorvastatin Calcium | Atorvastatin Calcium | 28 | 2,520 | $302.24 | — |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 27 | 2,430 | $182.31 | 11 |
| Levothyroxine Sodium | Levothyroxine Sodium | 23 | 2,070 | $313.84 | — |
| Amlodipine Besylate | Amlodipine Besylate | 21 | 1,890 | $144.04 | — |
| Diazepam | Diazepam | 18 | 570 | $59.37 | — |
| Metoprolol Succinate | Metoprolol Succinate | 17 | 1,530 | $128.36 | — |
| Famotidine | Famotidine | 17 | 1,200 | $48.20 | — |
| Breo Ellipta | Fluticasone/Vilanterol | 17 | 630 | $8,320.59 | — |
| Gabapentin | Gabapentin | 16 | 1,440 | $369.56 | — |
| Losartan Potassium | Losartan Potassium | 16 | 1,440 | $157.99 | — |
| Omeprazole | Omeprazole | 16 | 1,358 | $40.52 | — |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 15 | 1,350 | $161.09 | — |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 15 | 408 | $190.01 | — |
| Meclizine Hcl | Meclizine Hcl | 13 | 682 | $116.07 | — |
| Lisinopril | Lisinopril | 12 | 1,080 | $131.64 | — |
| Tramadol Hcl | Tramadol Hcl | 11 | 330 | $100.49 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - INTERNAL MEDICINE
I20071022000157
FL
2163405994
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History
NPI enumerated November 14, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Internal Medicine Providers in Miami
- Dr. Ausberto Bianchi, MD
- Dr. Mireya Garcia, MD
- Dr. Jose Morgan, MD
- Dr. Khatereh Khatami, MD
- Dr. Juan Reyes, MD
- Dr. Yoslay Perez, DO
Mailing Address
7085 Sw 47th St
Miami, FL 331554652
Phone: 7862697939